Not applicableEnded earlyNCT01465516What this trial is testingTreating Hispanic Patients Diagnosed With Hepatitis C Using BoceprevirWho this might be right forHepatitis C Infection Arrowhead Regional Medical Center 105
Early research (Phase 1)Study completedNCT00529321What this trial is testingImmunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C VirusWho this might be right forHepatitis C, Chronic Transgene 42
Early research (Phase 1)Study completedNCT00696904What this trial is testingStudy of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected SubjectsWho this might be right forHCV Infection AbbVie 133
Testing effectiveness (Phase 2)Study completedNCT00367887What this trial is testingA Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder SubjectsWho this might be right forHepatitis C Wyeth is now a wholly owned subsidiary of Pfizer 246
Testing effectiveness (Phase 2)Study completedNCT00664625What this trial is testingA Single Ascending Dose Study of BMS-791325 in HCV Infected SubjectsWho this might be right forChronic Hepatitis C Bristol-Myers Squibb 24
Post-approval studies (Phase 4)UnknownNCT02950870What this trial is testingEfficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.Who this might be right forChronic Hepatitis, C Virus University of Modena and Reggio Emilia 75
Testing effectiveness (Phase 2)Study completedNCT02765490What this trial is testingEfficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C InfectionWho this might be right forHepatitis C, Chronic Janssen Research & Development, LLC 365
Large-scale testing (Phase 3)Study completedNCT01399619What this trial is testingPhase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)Who this might be right forHepatitis C, Chronic Boehringer Ingelheim 310
Not applicableStudy completedNCT01641094What this trial is testingEffect of Teleprevir in Triple Therapy on Intrahepatic Immunological MechanismsWho this might be right forChronic Hepatitis C Foundation for Liver Research 20
Testing effectiveness (Phase 2)Study completedNCT03458481What this trial is testingPhase 2 Study of Yimitasvir Phosphate CapsulesWho this might be right forChronic HCV Infection Sunshine Lake Pharma Co., Ltd. 129
Early research (Phase 1)Study completedNCT01081158What this trial is testingSafety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 41
Not applicableEnded earlyNCT01250743What this trial is testingA Pilot Study of High-Dose, Intravenous Ascorbic Acid (Vitamin C) to Treat Hepatitis CWho this might be right forHepatitis C Health Innovations, Frontier Research Institute 10
Testing effectiveness (Phase 2)Study completedNCT00882908What this trial is testingTMC435 in Combination With Pegylated Interferon Alp\Fa-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received TreatmentWho this might be right forHepatitis C Tibotec Pharmaceuticals, Ireland 386
Large-scale testing (Phase 3)Study completedNCT00758043What this trial is testingA Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral ResponseWho this might be right forHepatitis C Vertex Pharmaceuticals Incorporated 540
Post-approval studies (Phase 4)Ended earlyNCT02940691What this trial is testingScale-up of Treatment of Hepatitis C Infection Among People Who Inject DrugsWho this might be right forHepatitis C Kirby Institute 32
Not applicableWithdrawnNCT00571714What this trial is testingPilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive PatientsWho this might be right forChronic Hepatitis C University of Nebraska
Post-approval studies (Phase 4)Ended earlyNCT00255008What this trial is testingPeg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 121
Testing effectiveness (Phase 2)UnknownNCT00332176What this trial is testingEvaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis CWho this might be right forChronic Hepatitis C BioWest Therapeutics Inc 50
Testing effectiveness (Phase 2)UnknownNCT01272310What this trial is testingClinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.Who this might be right forChronic Hepatitis C Sheba Medical Center 36
Testing effectiveness (Phase 2)Study completedNCT00157534What this trial is testingEvaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 InfectionWho this might be right forHepatitis C, Chronic BioWest Therapeutics Inc 43